Skin manifestations associated with checkpoint inhibitors
Abstract Immune checkpoint inhibitors (ICIs) are a relatively novel class of drugs whose administration has been approved for several malignancies. Adverse events are quite common, and the skin is the most frequently involved organ. In fact, regardless of the neoplasm being treated, more than 50% of...
Saved in:
Main Authors: | Gianluca Nazzaro (Author), Stefano Buffon (Author), Serena Giacalone (Author), Carlo Alberto Maronese (Author), Angelo Valerio Marzano (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding
by: Serena Giacalone, et al.
Published: (2023) -
Skin Manifestation Induced by Immune Checkpoint Inhibitors
by: Yamamoto T
Published: (2022) -
IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
by: Tristan V.M. Bruijn, MD, et al.
Published: (2024) -
Vitiligo: Unmet Need, Management and Treatment Guidelines
by: Angelo Valerio Marzano, et al.
Published: (2023) -
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
by: Silvia Ferrucci, et al.
Published: (2021)